We’re incredibly excited to announce the addition of Hongming Chen as President and Head of R&D. Hongming is a tenured biotech leader and will be an invaluable part of our team as we progress our AI-driven AiTEM platform to uncover novel drug candidates.

We are thrilled to announce the launch of METiS Therapeutics! Our $86 million Series A will support the advancement of our pipeline of novel assets with high therapeutic potential as well as our #AI-driven drug discovery and delivery platform.